Veralox Therapeutics
Founded
2017
2017
Clinical Trials
2
2
Publications
1
1
Technologies
AI Companies (Drug Discovery) Pharmaceutical and Drug DiscoveryVeralox Therapeutics develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type 1 diabetes. Based on an understanding of the molecular mechanisms of these diseases, these efforts will lead to new treatment paradigms and better outcomes for patients.
Become a Member to view additional information about this company